Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06755957 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effectiveness of Standard Exercises and Wall Angels Exercise in Young Adults With Kyphotic Posture

StatusCompleted
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Start date: Oct 1, 2024 to Dec 25, 2024 Show 6 more changesShow less
    • Trial status changed: Enrolling by Invitation → Completed
    • Primary completion pushed from Oct 3, 2024 to Mar 10, 2025
    • Final enrollment: 44 participants (planned 40)
    • Study completion date changed from estimate of Jan 20, 2025 to Mar 10, 2025
    • Eligibility criteria expanded, about 8 words
    • Study description revised
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Kyphosis-oriented exercise programs consist of isolated stretching, strengthening, and breathing exercises. However, the literature emphasizes that the body is a kinetic chain in many musculoskeletal disorders and supports holistic exercise approaches. To our knowledge, the effects of a complex exercise such as the Wall Angels exercise have not been studied in the kyphotic population. The aim of our study is to investigate whether the Wall Angels exercise combined with standard kyphosis exercises performed at home has additional effects and to contribute to the optimization of kyphosis rehabilitation programs.
Trial Details
NCT Number NCT06755957
Lead Sponsor Suleyman Demirel University
Conditions
(from sponsor)		 Kyphosis Thoracic, Exercise Therapy
Related terms Kyphosis
Enrollment 44 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov